Einträge von Ziepert, Marita auf dem Publikationsserver

Kosch, Robin, Limm, Katharina, Staiger, Annette M., Kurz, Nadine S., Seifert, Nicole, Oláh, Bence, Solbrig, Stefan , Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Schmitz, Norbert, Chteinberg, Emil, Siebert, Reiner, Spang, Rainer , Zacharias, Helena U., Ott, German, Oefner, Peter J. und Altenbuchinger, Michael (2025) Integration of high-throughput proteomic data and complementary omics layers with PriOmics. Genome Research, gr.279487.124. Volltext nicht vorhanden.

Houot, Roch, Poeschel, Viola, Altmann, Bettina, Angel, Stephanie, Thurner, Lorenz, Illmer, Thomas, Andre, Marc, Dreyling, Martin, Maisonneuve, Hervé, Tilly, Hervé, Mayer, Stephanie, Casasnovas, Olivier , Le Gouill, Steven, Offner, Fritz, Cartron, Guillaume, Kerkhoff, Andrea, Weber, Thomas, Hoffmann, Joerg, Ziepert, Marita, Klapper, Wolfram, Itti, Emmanuel, Hellwig, Dirk , Natchkebia, Giorgi, de Leval, Laurence, Rosenwald, Andreas, Haioun, Corinne, Dercle, Laurent, Gaulard, Philippe und Held, Gerhard (2022) Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. HemaSphere 6 (2), e672. Volltext nicht vorhanden.

Nordmo, Carmen, Glehr, Gunther, Altenbuchinger, Michael, Spang, Rainer, Ziepert, Marita, Horn, Heike, Staiger, Annette M., Ott, German, Schmitz, Norbert, Held, Gerhard, Einsele, Hermann, Topp, Max, Rosenwald, Andreas und Rauert-Wunderlich, Hilka (2021) Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphoma. Leukemia & Lymphoma 62 (5), S. 1107-1115. Volltext nicht vorhanden.

Kaddu-Mulindwa, Dominic , Altmann, Bettina, Held, Gerhard, Angel, Stephanie, Stilgenbauer, Stephan, Thurner, Lorenz, Bewarder, Moritz, Schwier, Maren, Pfreundschuh, Michael, Löffler, Markus, Menhart, Karin , Grosse, Jirka, Ziepert, Marita, Herrmann, Ken, Dührsen, Ulrich, Hüttmann, Andreas , Barbato, Francesco, Poeschel, Viola und Hellwig, Dirk (2021) FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials. European Journal of Nuclear Medicine and Molecular Imaging 48 (11), S. 3550-3559.

d'Amore, Francesco, Leppä, Sirpa, da Silva, Maria Gomes, Relander, Thomas, De Nully Brown, Peter, Weidmann, Eckhart, Lauritzsen, Grete Fossum, Pezzutto, Antonio, Van Hoof, Achiel, van Gelder, Michel, Doorduijn, Jeanette K, Wu, Ka Lung, Kluin-Nelemans, J.C., Lugtenburg, P.J., Jankovska, Milada, Merup, Mats, Fagerli, Unn-Merete, Walewski, Jan, Hagberg, Hans, Mariz, Jose Mario, Hansen, Per Boye, Nösslinger, Thomas, Janssens, Ann, Brandefors, Lena, Demuynck, Hilde, Schaafsma, Martyn Ronald, Christiansen, Ilse, Salek, David, Jyrkkiö, Sirkku, Prochazka, Vit, Zijlstra, Josee, Böhmer, L., Greil, Richard , Stevens, Wendy, Fijnheer, Rob, van Marwijk Kooy, Marinus, Grube, Matthias, Hopfinger, Georg, Van den Neste, Eric, Jantunen, Esa, Trümper, Lorenz, Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus und Toldbod, Helle (2012) First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy. Blood 120 (21), S. 57. Volltext nicht vorhanden.

d'Amore, Francesco, da Silva, Maria Gomes, Leppa, Sirpa , Relander, Thomas, Pezzutto, Antonio, Lauritzsen, Grete F., Weidmann, Eckhart, Van Gelder, Michel, Merup, Mats, Hagberg, Hans, Fagerli, Unn-Merete, Brown, Peter de Nully, Hansen, Per Boye, Mariz, Jose Mario, Jankovska, Milada, Walewski, Jan, Doorduijn, Jeanette, Van Hoof, Achiel, Christiansen, Ilse, Jyrkkiö, Sirkku, Kluin-Nelemans, J.C., van Marwijk Kooy, Marinus, Fijnheer, Rob, Stevens, Wendy, Zijlstra, Josee, Böhmer, L., Lugtenburg, P.J., Grube, Matthias, Prochazka, Vit, Salek, David, Greil, Richard , Trümper, Lorenz, Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus, Jantunen, Esa, Hopfinger, Georg, Neste, Eric Van den und Toldbod, Helle (2011) First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,. Blood 118 (21), S. 4110. Volltext nicht vorhanden.